IL10 and inflammatory bowel disease: Non-neutralizing anti-IL-10 autoantibodies, previously described in certain patients with IBD and lupus erythematosus, presumably have a different functional significance with respect to IL-10 signalling and appear unlikely to influence gut inflammation16, 18.